Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
6.67
-1.03 (-13.33%)
At close: Jan 17, 2025, 4:00 PM
6.75
+0.08 (1.28%)
After-hours: Jan 17, 2025, 7:47 PM EST
Candel Therapeutics Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$19.00
Upside
+185.07%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 → $19 | Strong Buy | Reiterates | $11 → $19 | +185.07% | Dec 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +65.04% | Nov 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +65.04% | Nov 13, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +65.04% | May 22, 2023 |
| BMO Capital | BMO Capital | Buy Maintains $9 → $3 | Buy | Maintains | $9 → $3 | -54.99% | May 15, 2023 |
| Credit Suisse | Credit Suisse | Buy Maintains $8 → $7 | Buy | Maintains | $8 → $7 | +5.03% | Mar 31, 2023 |
| Credit Suisse | Credit Suisse | Buy Maintains $10 → $8 | Buy | Maintains | $10 → $8 | +20.03% | Dec 7, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +65.04% | Dec 2, 2022 |
| BMO Capital | BMO Capital | Buy Maintains $18 → $12 | Buy | Maintains | $18 → $12 | +80.05% | Mar 31, 2022 |
| BMO Capital | BMO Capital | Buy Initiates $18 | Buy | Initiates | $18 | +170.07% | Nov 19, 2021 |
| UBS | UBS | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +35.03% | Aug 23, 2021 |
| Jefferies | Jefferies | Strong Buy Initiates $22 | Strong Buy | Initiates | $22 | +230.08% | Aug 23, 2021 |
| Credit Suisse | Credit Suisse | Buy Initiates $15 | Buy | Initiates | $15 | +125.06% | Aug 23, 2021 |